ENDO PHARMACEUTICALS WKN: A1XE6M ISIN: IE00BJ3V9050 Kürzel: EO7 Forum: Aktien Thema: Hauptdiskussion

Wir freuen uns sehr, dazu beizutragen, den COVID-19-Impfstoff von Novavax der Öffentlichkeit zugänglich zu machen“, sagte Blaise Coleman, President und CEO von Endo. „Unser Werk in Rochester, Michigan, hat eine lange Geschichte in der Herstellung kritischer Impfstoffe und steriler injizierbarer Produkte für den US-Markt und wir sind stolz darauf, bei einer so entscheidenden Initiative mit Novavax zusammenzuarbeiten. Diese Partnerschaft unterstreicht das Engagement von Endo, allen, denen wir dienen, zu helfen, ihr bestes Leben durch die Bereitstellung von lebensverbessernden Therapien zu führen."

Nichts neues

Einfach News um Angst zu verbieten

(DoW Jones) - Endo International PLC is moving toward a bankruptcy filing, potentially setting off intense conflicts with state and local governments that have sued the pharmaceuticals company for its alleged role in fueling the opioid crisis. Without a deal with opioid plaintiffs after years of negotiations, Endo is considering filing for bankruptcy as a means to restructure its more than $8 billion of debt and thousands of outstanding lawsuits, according to people familiar with the matter. The company has been in negotiations with a group of secured creditors since it failed to make interest payments owed to its junior bondholders last month, said the people. Endo is aiming to reach a deal with the secured creditors before it enters a near-term chapter 11 process, though is unlikely to file for bankruptcy with an agreement also in place with its junior bondholders and opioid plaintiffs, the people said, cautioning that the situation is fluid and circumstances may change. Other pharmaceutical companies, including Purdue Pharma LP and Mallinckrodt PLC, have sought bankruptcy protection to resolve opioid liabilities, filing for chapter 11 with settlements in place with most U.S. states. Endo declined to comment. Chief Executive Blaise Coleman said on an earnings call in May that the company continues to try to reach a broad settlement with opioid claimants, while exploring strategic alternatives that would allow it to move forward if it

Mist

Geht aber tiefer

Viel tiefer wird es nicht gehen. Gute Einstiegschancen

Komisch

Fällt immer weiter 🤔

Dip gekauft!

Fällt noch

Steigt oder fällt

Prognose für heute ?

Sehr gute woche